8CT Stock Overview
A technology company, develops marijuana and alcohol breathalyzer for employers, law enforcement, workplaces, and laboratories in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
My Notes
Capture your thoughts, links and company narrative
Cannabix Technologies Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.33 |
| 52 Week High | CA$0.58 |
| 52 Week Low | CA$0.12 |
| Beta | 2.29 |
| 1 Month Change | 26.15% |
| 3 Month Change | 40.17% |
| 1 Year Change | 164.52% |
| 3 Year Change | -24.07% |
| 5 Year Change | -17.30% |
| Change since IPO | 277.01% |
Recent News & Updates
Recent updates
Shareholder Returns
| 8CT | DE Electronic | DE Market | |
|---|---|---|---|
| 7D | 0% | 0.9% | 2.7% |
| 1Y | 164.5% | -24.8% | 17.0% |
Return vs Industry: 8CT exceeded the German Electronic industry which returned -24.8% over the past year.
Return vs Market: 8CT exceeded the German Market which returned 17% over the past year.
Price Volatility
| 8CT volatility | |
|---|---|
| 8CT Average Weekly Movement | 24.9% |
| Electronic Industry Average Movement | 5.8% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 11.1% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: 8CT's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: 8CT's weekly volatility (25%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2011 | n/a | Rav Mlait | cannabixtechnologies.com |
Cannabix Technologies Inc., a technology company, develops marijuana and alcohol breathalyzer for employers, law enforcement, workplaces, and laboratories in the United States. It develops tetrahydrocannabinol breath systems, including cannabix mass spectrum (MS) breath sampler for mass spectrometers, optimized for breath collection and ionization that replaces the chromatography step and offers clinical and toxicology laboratories that analyzes nonvolatile species in breath; and cannabix breath collection unit that collects breath samples from the field onto a novel cartridge, which is taken and analyzed with the MS breath sampler. The company offers Breath Logix (BR-LGX), an industrial series a fully automated breath alcohol screening system for employee, contractor, and visitor access control that is self-administered, non-invasive, and has both non-contact and direct straw modes.
Cannabix Technologies Inc. Fundamentals Summary
| 8CT fundamental statistics | |
|---|---|
| Market cap | €34.84m |
| Earnings (TTM) | -€2.24m |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-15.6x
P/E RatioIs 8CT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 8CT income statement (TTM) | |
|---|---|
| Revenue | CA$0 |
| Cost of Revenue | CA$0 |
| Gross Profit | CA$0 |
| Other Expenses | CA$3.33m |
| Earnings | -CA$3.33m |
Last Reported Earnings
Oct 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.029 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0% |
How did 8CT perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/16 12:55 |
| End of Day Share Price | 2025/02/14 00:00 |
| Earnings | 2024/10/31 |
| Annual Earnings | 2024/04/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Cannabix Technologies Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.